Mayo Clinic in Minnesota is conducting experimental laboratory tests aimed at identifying genes thought to be involved with genetic (also known as familial) focal segmental glomerulosclerosis. People interested in participating in these tests can call 507-266-1044 for more information.
The Mayo Nephrology Collaborative Group (MNCG) is developing and conducting studies aimed at treating people with renal parenchymal diseases, including focal segmental glomerulosclerosis. The MNCG is a consortium of nephrologists from Mayo Clinic in Minnesota, Florida and Arizona and from other centers across the United States.
See a list of publications by Mayo doctors on FSGS on PubMed, a service of the National Library of Medicine.
Nov. 19, 2012